ACS Nano Impact Factor

Evidence basis: this page was reviewed against ACS Nano's current ACS metrics page, ACS Nano author guidelines, ACS Open Science pricing pages, the ISSN Portal, SCImago, and live search results for "acs nano impact factor" on June 30, 2026. Manusights interpretation is limited to submission-fit patterns from pre-submission review work; official metric and author-requirement claims remain tied to publisher, JCR, or indexing sources.

The 17.3 impact factor tells you ACS Nano is a high-visibility nanoscience venue, not that the journal is the right target for every strong materials paper. The more useful interpretation is comparative. ACS Nano sits above most specialist nano journals and below the highest-authority Nature Portfolio nano venue, so it is a realistic target when the paper needs a broad nanoscience audience but does not have the field-changing breadth required for Nature Nanotechnology.

For an author, the number should trigger a fit check rather than a prestige reflex. A paper with excellent device performance can still be weak for ACS Nano if the abstract promises a nanoscale mechanism but the figures mainly show morphology and endpoint performance. A paper with moderate performance can be stronger if it proves why the nanoscale architecture changes transport, selectivity, stability, delivery, or assembly. That is why the JIF belongs beside characterization depth, benchmark quality, and scope fit, not above them.

• whether the journal has the citation visibility you want

• whether ACS Nano sits in the prestige range you are targeting

• whether the journal belongs on the shortlist with other strong nanoscience venues

• whether your manuscript fits the scope

• whether the editor will see enough novelty for review

• how fast the first decision will come back

• whether your article type is actually welcomed

Source: current ACS and Journal Citation Reports metric context for the 2026 release and 2025 data, public Journal Citation Reports-history directories for earlier years; verify exact historical values in Clarivate Journal Citation Reports before formal citation.

Treat older year-by-year values as planning context unless you can verify the exact data year in Clarivate Journal Citation Reports. The 2025-data JIF of 17.3 is up from 16.0 in the 2024 data year and from 15.8 in the 2023 data year, but the important pattern is the band: ACS Nano has stayed near the same high-visibility tier across recent Journal Citation Reports cycles.

That stability matters more than authors usually realize. A journal that spikes once can look more prestigious than it really is. ACS Nano looks more durable than that. The five-year JIF being close to the annual JIF reinforces the same point.

ACS Nano is often the journal authors choose when the paper is too substantial for a broad mid-tier materials venue but not obviously a Nature or Science story. It rewards strong nanoscience positioning, real mechanism, and broader relevance to the field.

Nano Letters can be a better home when the contribution is narrower but more novelty-heavy. Advanced Functional Materials becomes more attractive when the manuscript is really about functional performance, applications, or device-facing materials science. Small is often the more flexible fallback when the nano story is strong but the editorial bar at ACS Nano may be too tight.

ACS Nano does not behave like a pure metric target. Editors screen hard for:

• a clear nano-specific contribution, not a generic materials paper with nanoscale language added late

• enough mechanistic evidence to justify the main claim

• competitive benchmarking if the paper is about performance

• a story that matters beyond one narrow synthesis variation

If the paper is mainly incremental optimization, the impact factor does not help you. The scope and editorial threshold matter more.

Across our ACS Nano pre-submission reviews, three patterns create the most consistent early editorial hesitation. They are not the same as the public author-guideline checklist. The guideline can tell you that the abstract is capped at 250 words, that a cover letter is required, and that figures, tables, schemes, and equations should be embedded near the relevant text. It cannot tell you whether the manuscript reads like ACS Nano rather than a broad materials paper with nano vocabulary.

The ACS Nano "nano label on a materials paper" problem. The title and abstract say nanoparticles, nanofibers, MXenes, quantum dots, or nanocarriers, but the figures only prove synthesis and morphology. In a strong ACS Nano submission, the nanoscale feature changes a result the field cares about: transport, selectivity, stability, assembly, delivery, optical response, mechanical behavior, or biological interaction. If the manuscript would still be the same paper after replacing "nano" with "structured material," the ACS Nano case is not finished.

The ACS Nano characterization stack that stops too early. A draft may have attractive TEM, SEM, AFM, HRTEM, XRD, XPS, DLS, or spectroscopy panels, yet still fail to connect those panels to the central claim. Reviewers should not have to infer the mechanism from a schematic. If the abstract claims pathway control, interface engineering, or structure-property causality, the main figures need direct evidence for that claim: controls, in situ measurements, isotope or inhibitor logic, computational support, dose response, or equivalent tests. A beautiful image is not a mechanism.

The ACS Nano benchmark table that makes performance look better than it is. We often see device, catalysis, sensing, energy, and bio-nano manuscripts with a comparison table that mixes literature values from different protocols, electrolyte conditions, cell lines, irradiation settings, mass loadings, or normalization choices. ACS Nano readers will notice. The safer manuscript names the benchmark protocol, separates unlike conditions, explains why the comparison is fair, and moves weaker comparator details into Supporting Information rather than hiding them.

These are Manusights editorial-pattern observations, not ACS policy statements. They are specific failure patterns we see across ACS Nano-targeted drafts, and they matter because the metric can lure authors into asking the wrong question. The better question is not "Is 17.3 high enough?" It is whether the title, abstract, main figures, methods, controls, benchmark table, and cover letter make the ACS Nano fit legible before a busy editor has to reconstruct the case.

An ACS Nano submission readiness check can pressure-test those components before upload.

Use the impact factor as a shortlist filter, then ask the harder submission questions:

• Is the manuscript clearly nano-specific, not just nanoscale by description?

• Are the claims supported by mechanism, not only performance?

• Is the benchmarking good enough for a competitive nanoscience venue?

• Would a more application-facing journal actually be the more realistic target?

That is the real decision sequence. The JIF helps you place ACS Nano in the market. It does not replace the fit call.

The most common mistake is reading a high impact factor as proof that the journal is simply "better" than its alternatives. For submission planning, that is too crude.

Authors also overestimate how much the number compensates for weak editorial fit. A paper can look strong on citations, novelty language, or device performance and still fail fast if the editor sees it as too incremental, too descriptive, or too far outside the journal's center of gravity.

The better use of the metric is comparative:

• if you want a high-visibility nano journal, ACS Nano belongs in the discussion

• if you are choosing between several realistic journals, the impact factor helps you rank visibility

• if the scope fit is shaky, the metric should not persuade you to submit anyway

That is why strong authors use ACS Nano's JIF as context, not as the argument.

This page helps with market position, not final targeting. If you are choosing between ACS Nano and a near-peer journal for a real submission this month, you still need the companion questions: scope fit, editor behavior, review expectations, and editorial triage. The metric page is useful, but the actual submission decision should always move beyond the metric page.

That is where the journal-fit decision actually happens.

Submit if:

• The paper has a clear nano-specific contribution with solid mechanistic evidence, not just nanoscale language added to generic materials work

• Benchmarking against competing approaches is competitive and fair, as editors screen hard for this

• The story matters beyond one narrow synthesis variation and has broad relevance to the nanoscience or nanotechnology community

• You have a clear nanoscience narrative supported by mechanism, not only by device performance metrics

The 291,591 total-citation figure confirms ACS Nano's scale, but the rows that matter for formal evaluation still belong in Clarivate Journal Citation Reports. Use this page to understand the author decision, then verify self-citation, JCI, half-life, and category-rank values directly in the database before putting them in a grant, tenure, or dossier file.

ACS Nano's review culture reflects ACS editorial standards:

1. Complete characterization. Reviewers expect every material to be characterized by at least 3 independent techniques. TEM, XRD, XPS, DLS, or equivalent. Missing characterization triggers immediate revision.

1. Reproducibility data. Batch-to-batch variation for nanoparticle synthesis, replicate measurements for device performance. Single-run data isn't sufficient.

1. Application relevance. Pure synthesis without a demonstrated application is getting harder to publish here. Reviewers want to see why the material matters, not just that it was made.

1. Toxicity or biocompatibility data for biomedical applications. If you're proposing drug delivery or imaging applications, reviewers expect at minimum in vitro cytotoxicity data.

1. Scalability discussion. Reviewers increasingly ask whether the synthesis can be scaled beyond lab bench. A paragraph on practical scalability is now expected, even if full-scale data isn't available.

An ACS Nano characterization check can verify whether the characterization suite meets the journal's completeness standard before you submit.

Not all ACS Nano papers are created equal when it comes to citations. The journal spans a wide range of nanoscience topics, and certain subfields consistently outperform others in citation impact. Understanding these patterns helps you gauge whether your paper's topic aligns with where ACS Nano's readers are most engaged.

Energy nanomaterials dominate ACS Nano's most-cited papers because the community is large, the funding is substantial, and the application stakes are high. Biomedical nano benefits from the same dynamic, clinical relevance drives citation volume. For authors in more specialized subfields like nano-fabrication or environmental nano, the honest question is whether ACS Nano's broad readership will find your work or whether a more focused journal would deliver better per-paper visibility.

The journal's 2,421 articles per year mean every paper competes for attention. An ACS Nano subfield positioning check identifies whether the cross-field appeal is strong enough for ACS Nano's editorial screen or whether a specialized venue would deliver better per-paper visibility.

ACS Nano's JIF has been remarkably stable over the past decade, hovering between roughly 13 and 18. That stability tells a story about the journal's position in nanoscience: it is neither rising like a breakout journal nor declining like a fading brand. It has settled into a durable high-visibility tier.

The five-year JIF of 17.0 sitting close to the annual JIF of 17.3 supports the same read: ACS Nano papers get cited at a consistent rate over time. Compare this with Nature Nanotechnology's higher JIF tier and lower article volume, or Nano Letters at 9.1, which publishes shorter, sharper studies for a different nano-submission shape.

ACS Nano's competitive position is secure: it is a go-to venue for substantial nanoscience papers that need breadth, depth, and application relevance. For submission planning, that predictability is an asset; authors can evaluate fit against a stable tier rather than overreacting to one annual JIF move.